324 related articles for article (PubMed ID: 29527530)
21. Novel chimeric beta-lactamase CTX-M-64, a hybrid of CTX-M-15-like and CTX-M-14 beta-lactamases, found in a Shigella sonnei strain resistant to various oxyimino-cephalosporins, including ceftazidime.
Nagano Y; Nagano N; Wachino J; Ishikawa K; Arakawa Y
Antimicrob Agents Chemother; 2009 Jan; 53(1):69-74. PubMed ID: 18955524
[TBL] [Abstract][Full Text] [Related]
22. Ceftazidime Is the Key Diversification and Selection Driver of VIM-Type Carbapenemases.
Martínez-García L; González-Alba JM; Baquero F; Cantón R; Galán JC
mBio; 2018 May; 9(3):. PubMed ID: 29739906
[TBL] [Abstract][Full Text] [Related]
23. Role of a mutation at position 167 of CTX-M-19 in ceftazidime hydrolysis.
Kimura S; Ishiguro M; Ishii Y; Alba J; Yamaguchi K
Antimicrob Agents Chemother; 2004 May; 48(5):1454-60. PubMed ID: 15105092
[TBL] [Abstract][Full Text] [Related]
24. Proliferation and significance of clinically relevant β-lactamases.
Bush K
Ann N Y Acad Sci; 2013 Jan; 1277():84-90. PubMed ID: 23346859
[TBL] [Abstract][Full Text] [Related]
25. Structural Characterization of the D179N and D179Y Variants of KPC-2 β-Lactamase: Ω-Loop Destabilization as a Mechanism of Resistance to Ceftazidime-Avibactam.
Alsenani TA; Viviani SL; Kumar V; Taracila MA; Bethel CR; Barnes MD; Papp-Wallace KM; Shields RK; Nguyen MH; Clancy CJ; Bonomo RA; van den Akker F
Antimicrob Agents Chemother; 2022 Apr; 66(4):e0241421. PubMed ID: 35341315
[TBL] [Abstract][Full Text] [Related]
26. NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum beta-lactamases and carbapenemases.
Livermore DM; Mushtaq S; Warner M; Miossec C; Woodford N
J Antimicrob Chemother; 2008 Nov; 62(5):1053-6. PubMed ID: 18689875
[TBL] [Abstract][Full Text] [Related]
27. Biochemical characteristics of extended broad spectrum beta-lactamases.
Bush K; Singer SB
Infection; 1989; 17(6):429-33. PubMed ID: 2613337
[TBL] [Abstract][Full Text] [Related]
28. Increased structural flexibility at the active site of a fluorophore-conjugated beta-lactamase distinctively impacts its binding toward diverse cephalosporin antibiotics.
Wong WT; Chan KC; So PK; Yap HK; Chung WH; Leung YC; Wong KY; Zhao Y
J Biol Chem; 2011 Sep; 286(36):31771-80. PubMed ID: 21705325
[TBL] [Abstract][Full Text] [Related]
29. Systematic mutagenesis of the active site omega loop of TEM-1 beta-lactamase.
Petrosino JF; Palzkill T
J Bacteriol; 1996 Apr; 178(7):1821-8. PubMed ID: 8606154
[TBL] [Abstract][Full Text] [Related]
30. Deciphering the Evolution of Cephalosporin Resistance to Ceftolozane-Tazobactam in Pseudomonas aeruginosa.
Barnes MD; Taracila MA; Rutter JD; Bethel CR; Galdadas I; Hujer AM; Caselli E; Prati F; Dekker JP; Papp-Wallace KM; Haider S; Bonomo RA
mBio; 2018 Dec; 9(6):. PubMed ID: 30538183
[No Abstract] [Full Text] [Related]
31. Exploring the role of a conserved class A residue in the Ω-Loop of KPC-2 β-lactamase: a mechanism for ceftazidime hydrolysis.
Levitt PS; Papp-Wallace KM; Taracila MA; Hujer AM; Winkler ML; Smith KM; Xu Y; Harris ME; Bonomo RA
J Biol Chem; 2012 Sep; 287(38):31783-93. PubMed ID: 22843686
[TBL] [Abstract][Full Text] [Related]
32. Structural and Kinetic Insights into the "Ceftazidimase" Behavior of the Extended-Spectrum β-Lactamase CTX-M-96.
Ghiglione B; Rodríguez MM; Herman R; Curto L; Dropa M; Bouillenne F; Kerff F; Galleni M; Charlier P; Gutkind G; Sauvage E; Power P
Biochemistry; 2015 Aug; 54(32):5072-82. PubMed ID: 26228623
[TBL] [Abstract][Full Text] [Related]
33. Detection of TEM-, SHV- and CTX-M-type β-lactamase production among clinical isolates of Salmonella species.
Elumalai S; Muthu G; Selvam REM; Ramesh S
J Med Microbiol; 2014 Jul; 63(Pt 7):962-967. PubMed ID: 24866367
[TBL] [Abstract][Full Text] [Related]
34. Hydrolysis of third-generation cephalosporins by class C beta-lactamases. Structures of a transition state analog of cefotoxamine in wild-type and extended spectrum enzymes.
Nukaga M; Kumar S; Nukaga K; Pratt RF; Knox JR
J Biol Chem; 2004 Mar; 279(10):9344-52. PubMed ID: 14660590
[TBL] [Abstract][Full Text] [Related]
35. KPC-Mediated Resistance to Ceftazidime-Avibactam and Collateral Effects in Klebsiella pneumoniae.
Findlay J; Poirel L; Juhas M; Nordmann P
Antimicrob Agents Chemother; 2021 Aug; 65(9):e0089021. PubMed ID: 34228551
[TBL] [Abstract][Full Text] [Related]
36. Structural insights into the molecular mechanism of high-level ceftazidime-avibactam resistance conferred by CMY-185.
Kawai A; Shropshire WC; Suzuki M; Borjan J; Aitken SL; Bachman WC; McElheny CL; Bhatti MM; Shields RK; Shelburne SA; Doi Y
mBio; 2024 Feb; 15(2):e0287423. PubMed ID: 38179965
[TBL] [Abstract][Full Text] [Related]
37. Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum beta-lactamase CTX-M-15 and of its structurally related beta-lactamase CTX-M-3.
Poirel L; Gniadkowski M; Nordmann P
J Antimicrob Chemother; 2002 Dec; 50(6):1031-4. PubMed ID: 12461028
[TBL] [Abstract][Full Text] [Related]
38. Structural insights into substrate recognition and product expulsion in CTX-M enzymes.
Delmas J; Leyssene D; Dubois D; Birck C; Vazeille E; Robin F; Bonnet R
J Mol Biol; 2010 Jul; 400(1):108-20. PubMed ID: 20452359
[TBL] [Abstract][Full Text] [Related]
39. Extended-spectrum plasmid-mediated beta-lactamases.
Sirot D
J Antimicrob Chemother; 1995 Jul; 36 Suppl A():19-34. PubMed ID: 8543494
[TBL] [Abstract][Full Text] [Related]
40. Penicillanic Acid Sulfones Inactivate the Extended-Spectrum β-Lactamase CTX-M-15 through Formation of a Serine-Lysine Cross-Link: an Alternative Mechanism of β-Lactamase Inhibition.
Hinchliffe P; Tooke CL; Bethel CR; Wang B; Arthur C; Heesom KJ; Shapiro S; Schlatzer DM; Papp-Wallace KM; Bonomo RA; Spencer J
mBio; 2022 Jun; 13(3):e0179321. PubMed ID: 35612361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
